Medicare AdvantageCoverageMedium impact
MA07.002i, Ultraviolet Light Therapy for the Treatment of Dermatological Conditions
Independence Blue Cross·Dermatology·Medical Policy
Effective date
Apr 2, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA07.002i regarding ultraviolet light therapy for dermatological conditions has been reissued and will become effective April 2, 2025. This is a policy update that may affect coverage criteria, billing requirements, or documentation standards for UV light therapy procedures.
Action Required
By April 2, 2025: Billing team must review the complete MA07.002i policy document at the provided URL to identify specific changes to coverage criteria, prior authorization requirements, or billing procedures for ultraviolet light therapy treatments. Update billing protocols and inform providers of any new documentation or authorization requirements for Medicare Advantage patients receiving UV therapy.